✦ LIBER ✦

Heart disorders, age, race predict lipid-lowering drug use in diabetes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment gap in the use of lipid-loweri

✍ P. James; H. H. Tan; R. MacAlpine; G. Brennan; A. Emslie-Smith; A. D. Morris 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Changes in body composition and use of b

✍ Arnarson, A.; Ramel, A.; Geirsdottir, O. G.; Jonsson, P. V.; Thorsdottir, I. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 204 KB

MD3 EFFECT OF LIPID LOWERING DRUG USE ON

✍ V Thumula; Y Yang; PF Pace; BF Banahan; NE Wilkin; WB Lobb 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

2.P.78 Factors associated with non-use o

✍ K. Pyörälä; D. Vanuzzo; G.B. Ambrosio; D. De Bacquer; G. De Backer 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 177 KB

The benefit of early use of lipid-loweri

✍ Gottlieb, Shmuel; Leor, Jonathan; Shotan, Avraham; Hod, Hanoch; Boyko, Valentina 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Usefulness of Fasting Plasma Glucose to

✍ Leon A. Simons; Judith Simons; Yechiel Friedlander; John McCallum 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB